发明名称 ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS
摘要 Provided are processes for the synthesis of amino analogues from ketone starting materials.
申请公布号 US2016177354(A1) 申请公布日期 2016.06.23
申请号 US201615054011 申请日期 2016.02.25
申请人 Infinity Pharmaceuticals, Inc. 发明人 Austad Brian C.;Bahadoor Adilah;Belani Jitendra D.;Janardanannair Somarajannair;Wallerstein Sheldon L.;Keaney Gregg F.;White Priscilla L.;Johannes Charles W.
分类号 C12P17/18 主分类号 C12P17/18
代理机构 代理人
主权项 1. A process for preparing a compound of formula (II):or a salt thereof; from a compound of formula (I):or a salt thereof;wherein: R1 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —OR16, —C(O)R16, —CO2R16, —SO2R16, —C(O)N(R17)(R17), —[C(R16)2]q—R16, —[(W)—N(R17)C(O)]qR16, —[(W)—C(O)]R16, —[(W)—C(O)O]R16, —[(W)—OC(O)]qR16, —[(W)—SO2]qR16, —[(W)—N(R17)SO2]R16, —[(W)—C(O)N(R17)]qR17, [(W)—O]qR16, —[(W)—N(R17)]qR16, or —[(W)—S]qR16; wherein W is a diradical and q is 1, 2, 3, 4, 5, or 6; each R2 and R3 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, halo, —OR16, —OR16, —N(R17)2, or —SR16, or R2 and R3 taken together form a double bond or form a group  wherein Z is NR17, O, or C(R18)2; R4 is independently H, halo, —OR16, —N(R17)2, or —SR16; each R5 and R6, is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halo, —OR16, —N(R17)2, or —SR16; or R5 and R6 taken together with the carbon to which they are bonded form C═O, C═S, C═N—OR17, C═N—R17, C═N—N(R17)2, or form an optionally substituted 3-8 membered ring; each R7, R8, R9, R10, R11, R12 and R13 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halo, —OR16, —N(R17)2, or —SR16; or R10 and R11 taken together, or R11 and R12 taken together, form a double bond or form a group  wherein Z is NR17, O, or C(R18)2; each R14 and R15 is, independently, H, halo, —OR16, —N(R17)2, or —SR16; or R14 and R15 taken together with the carbon to which they are bonded form C═O or C═S; X is a bond or the group —C(R19)2—; wherein each R19 is, independently, H, alkyl, aralkyl, halo, —CN, —OR16, or —N(R17)2; R16 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R20)2]p—R21 wherein p is 0-6; or any two occurrences of R16 on the same substituent are taken together to form a 4-8 membered optionally substituted ring; R17 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, —C(═O)R20, —C(═O)OR20, —SO2R20, —C(═O)N(R20)2, or —[C(R20)2]p—R21 wherein p is 0-6; or any two occurrences of R17 on the same substituent are taken together to form a 4-8 membered optionally substituted ring; R18 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halo, —CN, —OR20, —OSi(R20)3, —C(═O)R20, —C(═O)OR20, —SO2R20 or —C(═O)N(R20)2; R20 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R20 on the same substituent are taken together to form a 4-8 membered optionally substituted ring; R21 is —OR22, —N(R22)C(═O)R22, —N(R22)C(═O)OR22, —N(R22)S2(R22), —C(═O)R22N(R22)2, —OC(═O)R22N(R22)(R22), —SO2N(R22)(R22), —N(R22)(R22), —C(═O)OR22, —C(═O)N(OH)(R22), —OS(O)2OR22, —S(O)2OR22, —OP(═O)(OR22)(OR22), —N(R22)P(O)(OR22)(OR22), or —P(═O)(OR22)(OR22); and R22 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl; or any two occurrences of R22 on the same substituent are taken together to form a 4-8 membered optionally substituted ring; said process comprising contacting a compound of formula (I) or a salt thereof, an amino donor molecule, and an omega amine transaminase enzyme in a solution to provide a compound of formula (II) or a salt thereof.
地址 Cambridge MA US